Etretinate and Alcohol/Food Interactions
There are 2 alcohol/food/lifestyle interactions with etretinate.
Etretinate Obesity
Moderate Potential Hazard, High plausibility
retinoids - elevated serum triglycerides
The use of retinoids is associated with elevations in serum triglycerides and cholesterol, and decreases in HDL. In addition to cardiovascular risks, elevation of serum triglycerides to greater than 800 mg/dL has been associated with fatal fulminant pancreatitis. Patients at increased risk for developing hypertriglyceridemia during retinoid therapy include those with diabetes mellitus, obesity, high alcohol consumption, or a family history of these conditions. Blood lipid determinations should be performed prior to initiation of therapy and at 1- to 2- week intervals until the lipid response to the drug is established (usually 4 to 8 weeks). Patients with preexisting hyperlipidemia may require closer monitoring during retinoid therapy, and adjustments made accordingly in their lipid-lowering regimen.
Etretinate High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)
Moderate Potential Hazard, High plausibility
retinoids - elevated serum triglycerides
The use of retinoids is associated with elevations in serum triglycerides and cholesterol, and decreases in HDL. In addition to cardiovascular risks, elevation of serum triglycerides to greater than 800 mg/dL has been associated with fatal fulminant pancreatitis. Patients at increased risk for developing hypertriglyceridemia during retinoid therapy include those with diabetes mellitus, obesity, high alcohol consumption, or a family history of these conditions. Blood lipid determinations should be performed prior to initiation of therapy and at 1- to 2- week intervals until the lipid response to the drug is established (usually 4 to 8 weeks). Patients with preexisting hyperlipidemia may require closer monitoring during retinoid therapy, and adjustments made accordingly in their lipid-lowering regimen.
Switch to professional interaction data
Etretinate drug interactions
There are 59 drug interactions with etretinate.
Etretinate disease interactions
There are 4 disease interactions with etretinate which include:
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Inflectra
Inflectra (infliximab-dyyb) is a monocloncal antibody used to treat a range of inflammatory ...
Amjevita
Amjevita (adalimumab-atto) is a biosimilar to Humira, it is used to treat chronic conditions ...
Acitretin
Acitretin systemic is used for pityriasis rubra pilaris, psoriasis, psoriatic arthritis
Ustekinumab
Ustekinumab injection is used to treat plaque psoriasis, ulcerative colitis, Crohn’s disease, and p ...
Infliximab
Infliximab infusion (brand names Avsola, Inflectra, Remicade, and others) reduces inflammation and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
